研究报告 |
|
|
|
|
研究报告Ⅱ型脊灰病毒抗原表位嵌合蛋白的免疫学研究 |
王晶1, 夏文跃1, 潘小霞2, 赵冰心1, 滕玉梅1, 李传印1, 杨筱舟1, 文喻玲1, 陈元鼎1 |
1. 中国医学科学研究院 北京协和医学院医学生物学研究所 云南省重大传染病疫苗研发重点实验室 昆明 650118;
2. 云南民族大学化学与生物技术学院民族药资源化学国家民委-教育部重点实验室 昆明 650118 |
|
Immunological Activity of a Chimeric Protein Carrying an Epitope of Type 2 Poliovirus on the VP6 of Rotavirus as a Vector |
WANG Jing1, XIA Wen-yue1, PAN Xiao-xia2, ZHAO Bing-xin1, TENG Yu-mei1, LI Chuan-yin1, YANG Xiao-zhou1, WEN Yu-ling1, CHEN Yuan-ding1 |
1. Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming 650118, China;
2. Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming 650500, China |
引用本文:
王晶, 夏文跃, 潘小霞, 赵冰心, 滕玉梅, 李传印, 杨筱舟, 文喻玲, 陈元鼎. 研究报告Ⅱ型脊灰病毒抗原表位嵌合蛋白的免疫学研究[J]. 中国生物工程杂志, 2016, 36(8): 1-8.
WANG Jing, XIA Wen-yue, PAN Xiao-xia, ZHAO Bing-xin, TENG Yu-mei, LI Chuan-yin, YANG Xiao-zhou, WEN Yu-ling, CHEN Yuan-ding. Immunological Activity of a Chimeric Protein Carrying an Epitope of Type 2 Poliovirus on the VP6 of Rotavirus as a Vector. China Biotechnology, 2016, 36(8): 1-8.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20160801
或
https://manu60.magtech.com.cn/biotech/CN/Y2016/V36/I8/1
|
[1] Kapikian A Z, Flores J, Hoshino Y, et al. Rotavirus:the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis, 1986, 153(5):815-822.
[2] Tate J E, Burton A H, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes:a systematic review and meta-analysis. Lancet Infect Dis, 2012,12(2):136-141.
[3] Teng Y, Zhao B, Pan X, et al. A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins. Viral Immunol, 2014, 27(3):96-104.
[4] Tang B, Gilbert J M, Matsui S M, et al. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology, 1997, 237(1):89-96.
[5] Matthijnssens J, Otto P H, Ciarlet M, et al. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol, 2012, 157(6):1177-1182.
[6] Badillo-Godinez O, Gutierrez-Xicotencatl L, Plett-Torres T, et al. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice. Vaccine, 2015,33(35):4228-4237.
[7] Zhao B, Pan X, Teng Y, et al. Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs. Virol Sin, 2015, 30(5):363-370.
[8] Wimmer E, Hellen C U, Cao X. Genetics of poliovirus. Annu Rev Genet, 1993, 27:353-436.
[9] Hogle J M, Filman D J. The antigenic structure of poliovirus. Philos Trans R Soc Lond B Biol Sci, 1989,323(1217):467-478.
[10] Rotavirus vaccines. WHO position paper-January 2013. Wkly Epidemiol Rec, 2013, 88:49-64.
[11] Desselberger U, Manktelow E, Li W, et al. Rotaviruses and rotavirus vaccines. Br Med Bull, 2009, 90(1):37-51.
[12] Vesikari T. Success of rotavirus vaccination in Africa:good news and remaining questions. Lancet Glob Health, 2016, 4:e76-77.
[13] Dunn G, Klapsa D, Wilton T, et al. Twenty-eight years of poliovirus replication in an immunodeficient individual:Impact on the global polio eradication initiative. PLoS Pathog, 2015, 11(8):e1005114.
[14] Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72:248-254.
[15] Glass R I, Bresee J S, Parashar U, et al. Rotavirus vaccines:past, present, and future. Arch Pediatr, 2005, 12(6):844-847.
[16] Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries:the potential impact, implementation challenges, and remaining questions. Vaccine, 2012, 30(Suppl 1):3-6.
[17] Shui I M, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA, 2012, 307(6):598-604.
[18] Buttery J, Danchin M H, Lee K J, et al. Intussusception following rotavirus vaccinead ministration:post-marketing surveillance in the National Immunization Program in Australia. Vaccine, 2011, 29(16):3061-3066.
[19] Wilder-Smith A, Leong W Y, Lopez L F, et al. Potential for international spread of wild poliovirus via travelers. BMC Med, 2015, 13(1):133.
[20] Liang X, Zhang Y, Xu W, et al. An outbreak of poliomyelitis caused by type1 vaccine-derived poliovirus in China. J Infect Dis, 2006, 194:545-551. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|